Vibranium.VC
Menlo Park, United States13
984K
8
4.33
0.38
- Stages of investment
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
- Geo focus
- Check size
- Up to 500K
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 10000000
- Fund raised date
- 2021-12-01
Analytics
- Total investments
- 13
- Lead investments
- 0
- Rounds per year
- 4.33
- Follow on index
- 0.38
- Investments by industry
- Artificial Intelligence (5)
- Software (5)
- Small and Medium Businesses (3)
- Advertising (3)
- Advertising Platforms (3) Show 14 more
- Investments by region
- United States (10)
- Israel (1)
- United Kingdom (1)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.46
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| HuLoop Automation, Inc. | 27 Feb 2024 | Software | Seed | 5M | United States, California, Auburn |
| MotionRay | 11 May 2022 | Internet, Hardware, Internet of Things, ISP | Seed | United States, Connecticut, Stamford |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| PAQ Therapeutics | Jul 5, 2025 | Biotechnology, Cancer Treatment | - | 39000000 USD | Burlington, Massachusetts |
| Therini Bio | May 15, 2025 | Biotech, Immunotherapy, Neurodegenerative Diseases | Early stage | 39000000 USD | Sacramento, California |
| Pelage Pharmaceutical | Aug 13, 2024 | Hair Loss Treatments, Molecular and Stem Cell Biology, Regenerative Medicine | Early stage | 14000000 USD | Los Angeles, California |
| Caraway Technologies | Nov 22, 2023 | Biopharmaceutical, Neurodegenerative Diseases, Rare Diseases, Small-Molecule Therapeutics | - | 610000000 USD | Cambridge, Massachusetts |
| Florence | Mar 30, 2023 | Healthcare, Health Tech, Software Platform | Early stage | 20000000 USD | New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.